ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Sonoma Pharmaceuticals (SNOA) Technical (Analysis) Reports Sonoma Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Sonoma Pharmaceuticals (SNOA)

Technical Analysis Report for USA stock SNOA Sonoma Pharmaceuticals. Dated: 31 Jul 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock SNOA Sonoma Pharmaceuticals then click here. or read Experts views on Sonoma Pharmaceuticals or Forecast & share price targets of Sonoma Pharmaceuticals

Sonoma Pharmaceuticals Opened at 1.09 and Closed at: 1.10, which is -2.73% of previous session's close. It moved within a range of 1.09 and 1.14
The session was a Bullish session with an average volume of 22901, which is 19.65% of previous session's volumes.

  • The stock has fallen, and its long term trend is also negative and in a downtrend.

A Dead cross was found 7 days back on short term averages

A Dead cross was found 2 days back on mid term averages

Support for tomorrow is 1.1 and resistance for tomorrow is 1.15
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 1.08, 1.06 resistance for tomorrow's hourly charts is 1.13, 1.16

10 Day SMA for Sonoma Pharmaceuticals (SNOA) is 1.14 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Sonoma Pharmaceuticals (SNOA) is 1.19 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Sonoma Pharmaceuticals (SNOA) is 1.16 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 1.5 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Sonoma Pharmaceuticals is 2.44 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Sonoma Pharmaceuticals is at 1.19 and 200 DMA is at 2.44, while 50 DMA and 100 DMA are at 1.16 and 1.5 respectively

Sonoma Pharmaceuticals (SNOA) moving average of 20 SMA is at 1.19 and 20 EMA is at 1.17

Sonoma Pharmaceuticals (SNOA) moving average of 50 SMA is at 1.16 and 50 EMA is at 1.24

Sonoma Pharmaceuticals (SNOA) moving average of 100 SMA is at 1.5 and 100 EMA is at 1.58

Sonoma Pharmaceuticals (SNOA) moving average of 200 SMA is at 2.44 and 200 EMA is at 2.08

Xencor Inc has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Xencor Inc, about 39.54% more returns!

Therapeuticsmd Inc has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Therapeuticsmd Inc, about 13.62% more returns!

Sonoma Pharmaceuticals has performed better than Sutro Biopharma in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!

Sonoma Pharmaceuticals has performed better than Redhill Biopharma in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!

Sonoma Pharmaceuticals has performed better than Moleculin Biotech in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!

Sonoma Pharmaceuticals has performed better than Karyopharm Therapeutics in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!

Iovance Biotherapeutics has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Iovance Biotherapeutics, about 4.35% more returns!

Sonoma Pharmaceuticals has performed better than Inovio Pharmaceuticals in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!

Gossamer Bio has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Gossamer Bio, about 5.01% more returns!

Corcept Therapeutics has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Corcept Therapeutics, about 32.32% more returns!

Argenx Se has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Argenx Se, about 3.38% more returns!

Sonoma Pharmaceuticals has performed better than Arbutus Biopharma in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!

Abeona Therapeutics has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Abeona Therapeutics, about 8.59% more returns!

Sonoma Pharmaceuticals Technical analysis of indicators

Price action analysis of Sonoma Pharmaceuticals (SNOA) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Sonoma Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a SELL signal for Sonoma Pharmaceuticals in short term and the sell signal is strong.

Sonoma Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.

Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down

CCI has generated a SELL signal for Sonoma Pharmaceuticals in short term and SELL signal is strong!

RSI is generating a SELL signal in short term but selling is losing momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Sonoma Pharmaceuticals is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 1.14 and Sonoma Pharmaceuticals SNOA stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Sonoma Pharmaceuticals SNOA stock. Volume based technical analysis of Sonoma Pharmaceuticals SNOA stock is negative.

Sonoma Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for USA stock SNOA Sonoma Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And SNOA Experts View which covers a lot of information including buying and selling signals

SNOA future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Sonoma Pharmaceuticals or View Candle Stick Charts here

Chart Sonoma Pharmaceuticals (SNOA)  Technical (Analysis) Reports Sonoma Pharmaceuticals [

Videos related to: Sonoma Pharmaceuticals (SNOA) Technical (Analysis) Reports Sonoma Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Sonoma Pharmaceuticals (SNOA)  Technical (Analysis) Reports Sonoma Pharmaceuticals [

 

Back to top